The amount of equity flowing into companies developing mRNA-based vaccines has significantly declined so far in 2025, ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for ...

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...

Moderna stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector.

A new Korean study controversially links COVID vaccines to six types of cancer, including lung and prostate, with higher ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for developing mRNA vaccines, but don’t be fooled into thinking these life-saving too ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for developing mRNA vaccines, but don’t be fooled into thinking these life-saving too ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for ...

While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.

President Donald Trump announced a deal with Pfizer to lower prescription drug costs through Medicaid, and a 'TrumpRx' ...

In September 2025, the Russian Federal Medical and Biological Agency announced that its mRNA-based vaccine Enteromix had ...

Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...